Cargando…

Can the Cognitive Phenotype in Neurofibromatosis Type 1 (NF1) Be Explained by Neuroimaging? A Review

Neurofibromatosis type 1 (NF1) is one of the most frequent monogenetic disorders. It can be associated with cognitive dysfunctions in several domains such as executive functioning, language, visual perception, motor skills, social skills, memory and/or attention. Neuroimaging is becoming more and mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Baudou, Eloïse, Nemmi, Federico, Biotteau, Maëlle, Maziero, Stéphanie, Peran, Patrice, Chaix, Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971173/
https://www.ncbi.nlm.nih.gov/pubmed/31993017
http://dx.doi.org/10.3389/fneur.2019.01373
_version_ 1783489666949840896
author Baudou, Eloïse
Nemmi, Federico
Biotteau, Maëlle
Maziero, Stéphanie
Peran, Patrice
Chaix, Yves
author_facet Baudou, Eloïse
Nemmi, Federico
Biotteau, Maëlle
Maziero, Stéphanie
Peran, Patrice
Chaix, Yves
author_sort Baudou, Eloïse
collection PubMed
description Neurofibromatosis type 1 (NF1) is one of the most frequent monogenetic disorders. It can be associated with cognitive dysfunctions in several domains such as executive functioning, language, visual perception, motor skills, social skills, memory and/or attention. Neuroimaging is becoming more and more important for a clearer understanding of the neural basis of these deficits. In recent years, several studies have used different imaging techniques to examine structural, morphological and functional alterations in NF1 disease. They have shown that NF1 patients have specific brain characteristics such as Unidentified Bright Objects (UBOs), macrocephaly, a higher volume of subcortical structures, microstructure integrity alterations, or connectivity alterations. In this review, which focuses on the studies published after the last 2 reviews of this topic (in 2010 and 2011), we report on recent structural, morphological and functional neuroimaging studies in NF1 subjects, with special focus on those that examine the neural basis of the NF1 cognitive phenotype. Although UBOs are one of the most obvious and visible elements in brain imaging, correlation studies have failed to establish a robust and reproducible link between major cognitive deficits in NF1 and their presence, number or localization. In the same vein, the results among structural studies are not consistent. Functional magnetic resonance imaging (fMRI) studies appear to be more sensitive, especially for understanding the executive function deficit that seems to be associated with a dysfunction in the right inferior frontal areas and the middle frontal areas. Similarly, fMRI studies have found that visuospatial deficits could be associated with a dysfunction in the visual cortex and especially in the magnocellular pathway involved in the processing of low spatial frequency and high temporal frequency. Connectivity studies have shown a reduction in anterior-posterior “long-range” connectivity and a deficit in deactivation in default mode network (DMN) during cognitive tasks. In conclusion, despite the contribution of new imaging techniques and despite relative advancement, the cognitive phenotype of NF1 patients is not totally understood.
format Online
Article
Text
id pubmed-6971173
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-69711732020-01-28 Can the Cognitive Phenotype in Neurofibromatosis Type 1 (NF1) Be Explained by Neuroimaging? A Review Baudou, Eloïse Nemmi, Federico Biotteau, Maëlle Maziero, Stéphanie Peran, Patrice Chaix, Yves Front Neurol Neurology Neurofibromatosis type 1 (NF1) is one of the most frequent monogenetic disorders. It can be associated with cognitive dysfunctions in several domains such as executive functioning, language, visual perception, motor skills, social skills, memory and/or attention. Neuroimaging is becoming more and more important for a clearer understanding of the neural basis of these deficits. In recent years, several studies have used different imaging techniques to examine structural, morphological and functional alterations in NF1 disease. They have shown that NF1 patients have specific brain characteristics such as Unidentified Bright Objects (UBOs), macrocephaly, a higher volume of subcortical structures, microstructure integrity alterations, or connectivity alterations. In this review, which focuses on the studies published after the last 2 reviews of this topic (in 2010 and 2011), we report on recent structural, morphological and functional neuroimaging studies in NF1 subjects, with special focus on those that examine the neural basis of the NF1 cognitive phenotype. Although UBOs are one of the most obvious and visible elements in brain imaging, correlation studies have failed to establish a robust and reproducible link between major cognitive deficits in NF1 and their presence, number or localization. In the same vein, the results among structural studies are not consistent. Functional magnetic resonance imaging (fMRI) studies appear to be more sensitive, especially for understanding the executive function deficit that seems to be associated with a dysfunction in the right inferior frontal areas and the middle frontal areas. Similarly, fMRI studies have found that visuospatial deficits could be associated with a dysfunction in the visual cortex and especially in the magnocellular pathway involved in the processing of low spatial frequency and high temporal frequency. Connectivity studies have shown a reduction in anterior-posterior “long-range” connectivity and a deficit in deactivation in default mode network (DMN) during cognitive tasks. In conclusion, despite the contribution of new imaging techniques and despite relative advancement, the cognitive phenotype of NF1 patients is not totally understood. Frontiers Media S.A. 2020-01-14 /pmc/articles/PMC6971173/ /pubmed/31993017 http://dx.doi.org/10.3389/fneur.2019.01373 Text en Copyright © 2020 Baudou, Nemmi, Biotteau, Maziero, Peran and Chaix. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Baudou, Eloïse
Nemmi, Federico
Biotteau, Maëlle
Maziero, Stéphanie
Peran, Patrice
Chaix, Yves
Can the Cognitive Phenotype in Neurofibromatosis Type 1 (NF1) Be Explained by Neuroimaging? A Review
title Can the Cognitive Phenotype in Neurofibromatosis Type 1 (NF1) Be Explained by Neuroimaging? A Review
title_full Can the Cognitive Phenotype in Neurofibromatosis Type 1 (NF1) Be Explained by Neuroimaging? A Review
title_fullStr Can the Cognitive Phenotype in Neurofibromatosis Type 1 (NF1) Be Explained by Neuroimaging? A Review
title_full_unstemmed Can the Cognitive Phenotype in Neurofibromatosis Type 1 (NF1) Be Explained by Neuroimaging? A Review
title_short Can the Cognitive Phenotype in Neurofibromatosis Type 1 (NF1) Be Explained by Neuroimaging? A Review
title_sort can the cognitive phenotype in neurofibromatosis type 1 (nf1) be explained by neuroimaging? a review
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971173/
https://www.ncbi.nlm.nih.gov/pubmed/31993017
http://dx.doi.org/10.3389/fneur.2019.01373
work_keys_str_mv AT baudoueloise canthecognitivephenotypeinneurofibromatosistype1nf1beexplainedbyneuroimagingareview
AT nemmifederico canthecognitivephenotypeinneurofibromatosistype1nf1beexplainedbyneuroimagingareview
AT biotteaumaelle canthecognitivephenotypeinneurofibromatosistype1nf1beexplainedbyneuroimagingareview
AT mazierostephanie canthecognitivephenotypeinneurofibromatosistype1nf1beexplainedbyneuroimagingareview
AT peranpatrice canthecognitivephenotypeinneurofibromatosistype1nf1beexplainedbyneuroimagingareview
AT chaixyves canthecognitivephenotypeinneurofibromatosistype1nf1beexplainedbyneuroimagingareview